We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKTA icon
701
Okta
OKTA
$24.7B
-3,642
Closed -$253K
OVV icon
702
Ovintiv
OVV
$17.3B
-17,481
Closed -$666K
PAGP icon
703
Plains GP Holdings
PAGP
$5.21B
-30,160
Closed -$447K
PARR icon
704
Par Pacific Holdings
PARR
$4.31B
-19,988
Closed -$532K
PAYX icon
705
Paychex
PAYX
$41.6B
-27,377
Closed -$3.06M
PBR icon
706
Petrobras
PBR
$125B
-113,670
Closed -$1.57M
PD icon
707
PagerDuty
PD
$816M
-23,275
Closed -$523K
PH icon
708
Parker-Hannifin
PH
$123B
-4,293
Closed -$1.67M
PII icon
709
Polaris
PII
$3.82B
-2,510
Closed -$304K
PLAY icon
710
Dave & Buster's
PLAY
$377M
-32,097
Closed -$1.43M
PM icon
711
Philip Morris
PM
$297B
-34,369
Closed -$3.36M
P
712
Everpure Inc
P
$25.7B
-20,117
Closed -$741K
PTEN icon
713
Patterson-UTI
PTEN
$3.98B
-18,385
Closed -$220K
PTGX icon
714
Protagonist Therapeutics
PTGX
$8.79B
-27,092
Closed -$748K
PWR icon
715
Quanta Services
PWR
$100B
-4,015
Closed -$789K
PYPL icon
716
PayPal
PYPL
$48.9B
-4,228
Closed -$282K
QGEN icon
717
Qiagen
QGEN
$8.54B
-16,735
Closed -$799K
QLYS icon
718
Qualys
QLYS
$5.1B
-1,717
Closed -$222K
QRVO icon
719
Qorvo
QRVO
$7.99B
-4,878
Closed -$498K
QS icon
720
QuantumScape Corp
QS
$3.21B
-23,157
Closed -$185K
RBLX icon
721
Roblox
RBLX
$25.4B
-63,607
Closed -$2.56M
RL icon
722
Ralph Lauren
RL
$22.6B
-2,529
Closed -$312K
ROST icon
723
Ross Stores
ROST
$80.5B
-8,652
Closed -$970K
RPD icon
724
Rapid7
RPD
$645M
-38,643
Closed -$1.75M
RTX icon
725
RTX Corp
RTX
$290B
-16,747
Closed -$1.64M

Similar funds

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.